Evidence map›Paper›PMID 39570791›Full record

ReviewRevista medica del Instituto Mexicano del Seguro Social2024

[Tuberculosis: Analysis of the history and development of multiple antibiotic resistance].

Yolanda Monserrath Jacobo-Delgado, Luis Adrián De Jesús-González, Bruno Rivas-Santiago

Abstract readHistorical ArticleReviewEnglish Abstract
In one paragraph

Review in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yolanda Monserrath Jacobo-DelgadoInstituto Mexicano del Seguro Social, Hospital General de Zona No. 1 Dr. Emilio Varela Lujan, Unidad de Investigación Biomédica. Zacatecas, Zacatecas, México.ORCID 0000-0003-2174-6277
Luis Adrián De Jesús-GonzálezInstituto Mexicano del Seguro Social, Hospital General de Zona No. 1 Dr. Emilio Varela Lujan, Unidad de Investigación Biomédica. Zacatecas, Zacatecas, México.ORCID 0000-0003-1415-6260
Bruno Rivas-SantiagoInstituto Mexicano del Seguro Social, Hospital General de Zona No. 1 Dr. Emilio Varela Lujan, Unidad de Investigación Biomédica. Zacatecas, Zacatecas, México.ORCID 0000-0002-1521-1519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is an ancient disease that has accompanied humanity for the last three thousand years and is considered the oldest infectious disease that still exists. The Mycobacterium tuberculosis bacillus was spread worldwide due to human migrations, and there is archaeological evidence of spinal tuberculosis cases in Egyptian and Andean mummies, as well as texts that attributed the disease to social factors before suspecting its infectious nature. Throughout its history, humans have dealt with this pathology by developing unusual and ineffective therapies, leading to a significant increase in the disease's mortality. In the past century, the first antibiotics were introduced, bringing hope to eradicate this disease. However, evolutionary pressure has led to the emergence of multi-drug-resistant strains. Today, the development of computational techniques, such as artificial intelligence, has given us new hope for generating drugs and potential immunomodulatory therapies. However, it is essential to remember that those who do not know their history are doomed to repeat it. In this review, we summarize the history of tuberculosis, analyzing theories of its possible origin, its discovery, the creation of the first empirical treatments, vaccines, the emergence of new antibiotics, and how the mycobacterium quickly develops resistance.

Indexed as

Mycobacterium tuberculosisAntitubercular AgentsDrug Resistance, Multiple, BacterialHistory, 15th CenturyHistory, 16th CenturyHistory, 17th CenturyHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHistory, AncientHistory, MedievalHumansTuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsAntituberculososFarmacorresistencia BacterianaHistoriaMycobacterium tuberculosis

Identifiers

PMID39570791
PMCPMC12539873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.